Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
Rangeley Capital, LLC's Holding History (CIK: 0001517796)
Note: Option positions (PUT/CALL) are excluded.
Q2 2025
Shares
33,729
Value ($000)
$372
Avg Close
$9.72
Range
$7.90 - $11.82
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2025
33,729
$372
$9.72
$7.90 - $11.82